Sort
21,453 grants matching “tuberculosis”
Type I IFN-dependent and independent contributions to the outcomes of early innate immune cell interactions during HIV/TB co-infection
$872,144Christina Leigh Stallings · Washington University · R01 · FY2025 · AI
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB
$872,044Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2020 · AI
A systems analysis of drug tolerance in Mycobacterium tuberculosis
$871,572Nitin S Baliga · Institute For Systems Biology · R01 · FY2017 · AI
A systems approach to manipulate microbial adaptation to structured environments
$871,106Nitin S Baliga · Institute For Systems Biology · R01 · FY2023 · AI
Histoplasmosis Induction and Consolidation Therapy Factorial Randomized Clinical Trial (HISTO-FACT)
$870,925Nathan Bahr · University Of Minnesota · R01 · FY2025 · AI
Project 1 Immunometabolic Determinants of Susceptibility
$870,530Christopher M Sassetti · Univ Of Massachusetts Med Sch Worcester · P01 · FY2024 · AI
Function of granulysin
$870,505Alan Krensky · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Regulation of RANTES expression in T lymphocytes
$870,505Alan Krensky · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Integrating genomic and spatial approaches for targeted control of HIV-associated tuberculosis epidemics
$870,052Theodore H Cohen · Yale University · R01 · FY2020 · AI
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.
$869,573Beatriz Grinsztejn · Fundacao Oswaldo Cruz · UM1 · FY2025 · AI
Role of Coupled Amino Acids in the Mechanisms of Enzyme Catalysis
$869,536Mary Jo Ondrechen · Northeastern University · · FY2022 · BIO
Development of Aersolized Vaccines
$869,351Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Lesion-centric optimization of multidrug therapies for tuberculosis
$869,259Bree Beardsley Aldridge · Tufts University Boston · R01 · FY2020 · AI
Human Genetic Dissection of Exit from Latency in Tuberculosis
$869,244Jean-Laurent Casanova · Weill Medical Coll Of Cornell Univ · U19 · FY2016 · AI
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
$869,240Shabaana A. Khader · Washington University · R01 · FY2022 · AI
A systems approach to manipulate microbial adaptation to structured environments
$869,107Nitin S Baliga · Institute For Systems Biology · R01 · FY2022 · AI
Promoting Adherence to TB Regimens in High-Risk Youth
$868,916San Diego State University · R01 · FY2003 · HL
A systems analysis of drug tolerance in Mycobacterium tuberculosis
$868,716Nitin S Baliga · Institute For Systems Biology · R01 · FY2024 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$868,304University Of Pittsburgh At Pittsburgh · U01 · FY2000 · AI
U.T. SOUTHWESTERN ADULT AIDS CLINICAL TRIALS UNIT
$868,300University Of Texas Sw Med Ctr/Dallas · U01 · FY2000 · AI
Synthetic Nanoparticle-antibody (SNAb) Based Depletion of Myeloid-Derived Suppressor Cells for TB Host-Directed Therapy
$867,492Jyothi Rengarajan · Emory University · R01 · FY2023 · AI
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB
$867,304Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2022 · AI
VACCINE AND EVALUATION TREATMENT UNITS
$867,107Robert Belshe · Saint Louis University · N01 · FY2015 · AI
Risk of Neonatal Vaccination for HIV/SIV Exposed Infants
$867,023Donald L Sodora · Seattle Biomedical Research Institute · R01 · FY2016 · DE
Broad spectrum antibacterials selectively targeting an un-drugged site on the ribosome
$866,989Charles Testa · Curza Inc · R01 · FY2017 · AI